Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The hypothesis for this study is that potent anti-secretory therapy with high dose PPI
improves asthma control regardless of either asthma severity or the presence of GERD
symptoms.